Hopital Foch
Clinical trials sponsored by Hopital Foch, explained in plain language.
-
Diabetes drug shows promise against deadly brain tumor
Disease control Recruiting nowThis study tests whether adding metformin, a common diabetes drug, to standard radiation and chemotherapy can help people with a specific type of glioblastoma (a fast-growing brain cancer). The trial includes about 64 adults whose tumors have a unique energy profile. The goal is …
Phase: PHASE2 • Sponsor: Hopital Foch • Aim: Disease control
Last updated May 26, 2026 08:51 UTC
-
Timing is everything: late scans may spot bladder cancer spread better
Diagnosis Recruiting nowThis study looks at whether taking PET scans later (2.5 hours after injection) finds lymph node spread in muscle-invasive bladder cancer more accurately than standard scans (1 hour after). About 66 adults with this cancer will get both scans, and results will be compared to surgi…
Phase: NA • Sponsor: Hopital Foch • Aim: Diagnosis
Last updated May 04, 2026 16:19 UTC
-
Hormone boost may improve IVF success for women with endometriosis
Symptom relief Recruiting nowThis study tests whether giving a GnRH agonist hormone injection before a frozen embryo transfer can improve pregnancy rates in women with endometriosis or adenomyosis. About 180 women aged 18-36 will be randomly assigned to receive either the hormone plus standard estrogen/proge…
Phase: PHASE2, PHASE3 • Sponsor: Hopital Foch • Aim: Symptom relief
Last updated May 26, 2026 08:33 UTC
-
Ear stimulation device could ease endometriosis pain
Symptom relief Recruiting nowThis study tests a non-invasive device that stimulates the vagus nerve through the ear to reduce chronic pelvic pain caused by endometriosis. About 72 women with endometriosis-related pain will use the device and report their symptom changes. The goal is to see if this gentle sti…
Phase: NA • Sponsor: Hopital Foch • Aim: Symptom relief
Last updated May 26, 2026 08:30 UTC
-
Scientists hunt for clues to stop uterus transplant rejection
Knowledge-focused Recruiting nowThis study aims to understand why the body sometimes rejects a transplanted uterus. Researchers will analyze blood, tissue, and swab samples from 30 participants, including transplant recipients, donors, and healthy women. The goal is to find new, non-invasive markers that can pr…
Phase: NA • Sponsor: Hopital Foch • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC